Star Therapeutics

NEWS

Drug Development

Star Therapeutics Starts a Family with Electra

Star Therapeutics has exited stealth mode and announced a spin-off company, Electra Therapeutics.

February 16, 2022

3 min read

Hayley Shasteen

Business

Money on the Move: February 9 – 15

As the market seems to be taking a turn against biotech stock, more companies are opting for private funding instead of going public for the moment. And VC firms are happy to jump in.

February 15, 2022

3 min read

Kate Goodwin

IN THE PRESS

Press Releases

Star Therapeutics Announces Oversubscribed $125 Million Series D Financing

September 30, 2025

5 min read

Press Releases

Star Therapeutics Receives FDA Fast Track Designation for VGA039 in Von Willebrand Disease (VWD)

January 7, 2025

2 min read

Press Releases

Star Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference

January 2, 2025

1 min read

Business

Star Therapeutics Appoints Scott Robertson, MBA, as Chief Business Officer and Chief Financial Officer

January 3, 2024

2 min read

Biotech Bay

Star Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference

January 2, 2024

1 min read

Business

Star Therapeutics Appoints Matthew Fust as Independent Director and Board Audit Chair

December 5, 2023

2 min read

Biotech Bay

Star Therapeutics Raises $90 Million Financing to Accelerate Its Pipeline of Novel Antibody Therapies and Growth of Its Portfolio Companies

September 5, 2023

3 min read

Drug Development

Star Therapeutics emerges from stealth mode raising $100M in financing since inception to be an innovation engine for rare disease therapies

February 16, 2022

4 min read

JOBS